Skip to content Skip to footer
Dr

Farhad Dehkhoda

Email: 
Phone: 
+61 7 336 53094

Overview

Availability

Dr Farhad Dehkhoda is:
Available for supervision

Works

Search Professor Farhad Dehkhoda’s works on UQ eSpace

21 works between 2013 and 2026

21 - 21 of 21 works

2013

Journal Article

The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors

Byron, Sara A., Chen, Huaibin, Wortmann, Andreas, Loch, David, Gartside, Michael G., Dehkhoda, Farhad, Blais, Steven P., Neubert, Thomas A., Mohammadi, Moosa and Pollock, Pamela M. (2013). The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors. NeoPlasia, 15 (8), 975-988. doi: 10.1593/neo.121106

The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors

Funding

Current funding

  • 2026 - 2027
    Leveraging crosstalk to mitigate opioid induced ventilatory impairment
    Australian & New Zealand College of Anaesthetists
    Open grant

Supervision

Availability

Dr Farhad Dehkhoda is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Dr Farhad Dehkhoda's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au